FindTrial
Sign In

The clinical outcomes of coronavirus (COVID-19) patients undergoing peritoneal and hemodialysis therapy in China

The clinical outcomes of coronavirus (COVID-19) patients undergoing peritoneal and hemodialysis therapy in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300078570
Enrollment
Unknown
Registered
2023-12-12
Start date
2023-04-15
Completion date
Unknown
Last updated
2023-12-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19

Interventions

Peritoneal dialysis group:N/A
Hemodialysis group:N/A

Sponsors

The Second Affiliated Hospital of Xuzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: All patients who underwent peritoneal dialysis or hemodialysis at our center between December 7, 2019 and January 31, 2019.

Exclusion criteria

Exclusion criteria: (1) Patients converted to kidney transplantation during follow-up; (2) Pulmonary infection caused by other diseases during the follow-up period and cannot be distinguished from the novel coronavirus pneumonia;

Design outcomes

Primary

MeasureTime frame
functional status;mental health;infection status;—

Secondary

MeasureTime frame
recovery time;—

Countries

China

Contacts

Public ContactXinglei Zhou

The Second Affiliated Hospital of Xuzhou Medical University

dzhouxinglei@163.com+86 138 5209 1980

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026